Showing 3901-3910 of 5623 results for "".
- Ocugen to Present on Modifier Gene Therapy Platform at ARVO 2023https://modernod.com/news/ocugen-to-present-on-modifier-gene-therapy-platform-at-arvo-2023/2481547/Ocugen announced that the company will present on its modifier gene therapy platform, including OCU400 for the treatment of retinitis pigmentosa and Leber congenital amaurosis; OCU410 for the treatment dry age-related macular degeneration (dry AMD); OCU410ST for the treatment of St
- Visus Therapeutics Announces Positive Topline Clinical Data from Phase 3 Trial of Brimochol PF for the Treatment of Presbyopiahttps://modernod.com/news/visus-therapeutics-announces-positive-topline-clinical-data-from-phase-3-trial-of-brimochol-pf-for-the-treatment-of-presbyopia/2481543/Visus Therapeutics reported positive topline results from its phase 3 pivotal BRIO-I trial. BRIO-I met the prespecified primary study endpoints agreed upon with the FDA and EMA/MHRA, demonstrating contribution of elements for the once-daily, fixed-dose combination, Brimochol PF, over both ac
- Iridex Announces US Launch of Next Generation PASCAL Laser with MicroPulsehttps://modernod.com/news/iridex-launches-next-gen-pascal-laser-with-micropulse-in-us/2481542/Iridex announced the full market launch of the next generation Iridex PASCAL platform. First offered in limited release in late 2022, the PASCAL is designed to provide an advanced technology package combining fast and precise pattern scanning capabilities, Endpoint Management Techn
- Nidek Launches the NT-1/1e Non Contact Tonometerhttps://modernod.com/news/nidek-launches-the-nt-11e-non-contact-tonometer/2481535/Nidek has announced the launch of the NT-1/1e non contact tonometer models. As an addition to same series that includes the NT-1p, the NT-1/1e non-contact tonometers were developed without the pachymetry function to address market demand. The NT-1p/1 perform fully automated measur
- Ocutrx Technologies Acquires Circuit Board Manufacturing Company Spectrum Advanced Manufacturing Technologieshttps://modernod.com/news/ocutrx-technologies-acquires-circuit-board-manufacturing-company-spectrum-advanced-manufacturing-technologies/2481531/Ocutrx Technologies announced it has acquired Spectrum Advanced Manufacturing Technologies, a Colorado-based electronics manufacturing and assembly company. Terms of the deal were not disclosed. With this acquisition, the consolidated Oxutrx_Spectrum company now
- Aviceda Announces FDA Clearance of the IND Application Enabling Phase 2 Trials for GA Drug Candidatehttps://modernod.com/news/aviceda-announces-fda-clearance-of-the-ind-application-enabling-phase-2-trials-for-geographic-atrophy-drug-candidate/2481529/Aviceda Therapeutics announced that the FDA has cleared the IND for AVD-104, enabling the company to proceed with initiating phase 2 clinical trials of its lead intravitreal ocular asset for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The Pha
- Bausch + Lomb and Heidelberg Engineering Introduce SeeLuma Fully Digital Surgical Visualization Platformhttps://modernod.com/news/bausch-lomb-and-heidelberg-engineering-introduce-seeluma-fully-digital-surgical-visualization-platform/2481528/Bausch + Lomb and Heidelberg Engineering announced the introduction of the SeeLuma Fully Digital Surgical Visualization Platform, which is designed to p
- NEI: Extremely Rare Gene Variants Point to a Potential Cause of AMDhttps://modernod.com/news/nei-extremely-rare-gene-variants-point-to-a-potential-cause-of-amd/2481519/A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD). The variants generate malformed proteins that alter the stability of the membrane attack complex (MAC), which may drive
- EverSight Launches Preloaded DMEK EndoGlidehttps://modernod.com/news/eversight-launches-preloaded-dmek-endoglide-1/2481517/Nonprofit eye bank Eversight announced the availability of Descemet’s membrane endothelial keratoplasty (DMEK) tissue preloaded in EndoGlide, offering corneal surgeons a fourth preloaded DMEK option to further s
- Horus Pharma Group Launches Nordic Subsidiaryhttps://modernod.com/news/horus-pharma-group-launches-nordic-subsidiary/2481515/Horus Pharma, an independent French laboratory specializing in ophthalmology, has opened of a new subsidiary. From its base in Stockholm, Sweden, Horus Pharma Nordic will cover Sweden, Norway, Finland and Denmark. Horus Pharma develops, patents and markets preservative-free ey